Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2011 | 6 | 6 | 713-719
Tytuł artykułu

Cutaneous yeast microflora in patients with atopic dermatitis

Treść / Zawartość
Warianty tytułu
Języki publikacji
The skin of persons with atopic dermatitis (AD) is very susceptible to cutaneous infection, and some yeast species may also aggravate AD. The total yeast population of an AD patient’s skin and its relation with individual age and body part remains poorly characterized. The aim of this study was to clarify the differences in cutaneous yeast flora by age and body parts of AD patients. By swabbing affected body parts (hands, legs, face, neck or trunk), 241 samples were collected from patients with AD (132 children and 109 adults), and as controls, 40 samples were taken from healthy individuals (20 children, 20 adults). In all, 89 (36.9%) of samples were positive; the yeast isolated belonged to three genera: Candida (27.4%), Malassezia (6.6%), and Rhodotorula (2.9%). Cutaneous colonization with yeasts was two-fold higher in the adults than in children (P<0.0001). The distribution of the yeast species was dependent on the body part sampled: Malassezia predominated in the face, neck, and trunk regions (P=0.0047); Candida more frequently colonized hands and legs (P=0.0029). Our study showed that cutaneous yeast flora and distribution of yeast species depends significantly on the age of the AD patient and the body part affected by atopic dermatitis.
Słowa kluczowe

Opis fizyczny
  • Faculty of Medicine, Clinic of children diseases, Vilnius University, Antakalnio 57, LT-10207, Vilnius, Lithuania
  • Department of Microbiology and Biotechnology, Faculty of Natural Sciences, Vilnius University, M.K. Ciurlionio 21/27, LT-03101, Vilnius, Lithuania
  • [1] Akdis C.A., Akdis M., Bieber T., Bindslev-Jensen C., Boguniewicz M., Eigenmann P., et al., Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report, Allergy, 2006, 61, 969–987 [Crossref]
  • [2] Williams H., Robertson C., Stewart A., Ait-Khaled N., Anabwani G., Anderson R., et al., Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood, J Allergy Clin Immunol, 1999, 103, 125–138[Crossref]
  • [3] Batiles Garrido J., Torres-Borego J., Bonilio Perales A., Rubi Ruiz T., González Jiménez Y., Momblán De Cabo J., et al., Prevalence and factors linked to atopic eczema in 10- and 11-year-old schoolchildren. Isaac 2 in Almeria, Spain, Allergol Immunopathol, 2010, 38, 174–180[Crossref]
  • [4] Simpson C.R., Newton J., Hippisley-Cox J., Sheikh A., Trends in the epidemiology and prescribing of medication for eczema in England, J R Soc Med, 2009, 102, 108–117[Crossref]
  • [5] Hwang C.Y., Chen Y.J., Lin M.W., Chen T.J., Chu S.Y., Chen C.C., et al., Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007, Acta Derm Venereol, 2010, 90, 589–594[Crossref]
  • [6] Asher M.I., Montefort S., Bjorksten B., Lai C.K., Strachan D.P., Weiland S.K., et al., Worldwide time trends in the prevalence of symptoms of astma, allergic rhinoconjunctivitis, and egzema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys, Lancet, 2006, 368, 733–743[Crossref]
  • [7] Strachan D.P., Hay fever, hygiene and household size, Br Med, 1989, 299, 1259–1260[Crossref]
  • [8] Lubbe J., Secondary infections in patients with atopic dermatitis, Am J Clin Dermatol, 2003, 4, 641–654[Crossref]
  • [9] Ashbee H.R., Evans E.G.V., Immunology of diseases associated with Malassezia species, Clin Microbiol Rev, 2002, 15, 21–57[Crossref]
  • [10] Nakabayshi A., Sei Y., Guillot J., Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects, Med Mycol, 2000, 38, 337–341 [Crossref]
  • [11] Savolainen J., Lintu P., Kosonen J., Kortekangas-Savolainen O., Viander M., Pène J., et al., Pityrosporum and Candida specific and non-specific humoral, cellular and cytokine responses in atopic dermatitis patients, Clin Exp Allergy, 2001, 31, 125–134 [Crossref]
  • [12] Rincón S., Celis A., Sopó L., Motta A., Cepero de Garcia M.C., Malassezia yeast species isolated from patients with dermatologic lesions, Biomedica, 2005, 25, 189–195 [Crossref]
  • [13] Yim S.M., Kim J.Y., Ko J.H., Lee Y.W., Choe Y.B., Ahn K.J., Molecular analysis of Malassezia micro-flora on the skin of the patients with atopic dermatitis, Ann Dermatol, 2010, 22, 41–47[Crossref]
  • [14] Scheynius A., Johansson C., Buentke E., Zargari A., Linder M.T., Atopic eczema/dermatitis syndrome and Malassezia, Int Arch Allergy Immunol, 2002, 127, 161–169[Crossref]
  • [15] Selander C., Zargari A., Möllby R., Rasool O., Scheynius A., Higher pH level, corresponding to that on the skin of patients with atopic eczema, stimulates the release of Malassezia sympodialis allergens, Allergy, 2006, 61, 1002–1008[Crossref]
  • [16] Nikkels A.F., Pierard G.E., Framing the future of antifungals in atopic dermatitis, Dermatology, 2003, 206, 398–400[Crossref]
  • [17] Baldo B.A., Allergenic crossreactivity of fungi with emphasis on yeasts: strategies for further study, Clin Exp Allergy, 1995, 25, 488–492[Crossref]
  • [18] Huang X., Johansson S.G.O., Zargari A., Nordvall S.L., Allergen cross reactivity between Pityrosporum orbiculare and Candida albicans, Allergy, 1995, 50, 648–656[Crossref]
  • [19] Lintu P., Savolainen J., Kalimo K., Kortekangas-Savolainen O., Nermes M., Terho E.O., Crossreacting IgE and IgG antibodies to Pityrosporum ovale mannan and other yeasts in atopic dermatitis, Allergy, 1999, 54, 1067–1073[Crossref]
  • [20] Yasueda H., Hashida-Okado T., Saito A., Uchida K., Kuroda M., Onishi Y., et al., Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur, Biochemical and Biophysical research communications, 1998, 248, 240–244[Crossref]
  • [21] Wagner S., Breiteneder H., Simon-Nobbe B., Susani M., Krebitz M., Niggemann B., et al., Hev b 9, an enolase and a new cross-reactive allergen from Hevea latex and molds. Purification, characterization, cloning and expression, Eur J Biochem, 2000, 267, 7006–7014[Crossref]
  • [22] O’Neil C.E., Horner W.E., Reed M.A., Lopez M., Lehrer S.B., Evaluation of Basidiomycete and Deuteromycete (Funfi Imperfecti) extracts for shared allergenic determinants, Clin Exp Allergy,1990, 20, 533–538[Crossref]
  • [23] Andersson A., Rasool O., Schmidt M., Kodzius R., Fluckiger S., Zargari A., et al., Cloning, expression and characterization of two new IgE-binding proteins from the yeast Malassezia sympodialis with sequence similarities to heat shock proteins and manganese superoxide dismutase, Eur J Biochem, 2004, 271, 1885–1894[Crossref]
  • [24] Aspres N., Anderson C., Malassezia yeasts in the pathogenesis of atopic dermatitis, Australas J Dermatol, 2004, 45, 199–207[Crossref]
  • [25] Sugita T., Tajima M., Tsubuku H., Tsuboi R., Nishikawa A., Quantitative analysis of cutaneous Malassezia in atopic dermatitis patients using realtime PCR, Microbiol Immunol, 2006, 50, 549–552 [Crossref]
  • [26] Kato H., Sugita T., Ishibashi Y., Nishikawa A., Detection and quantification of specific IgE antibodies against eight Malassezia species in sera of patients with atopic dermatitis by using an enzymelinked immunosorbent assay, Microbiol Immunol, 2006, 50, 851–856 [Crossref]
  • [27] Takahata Y., Sugita T., Kato H., Nishikawa A., Hiruma M., Muto M., Cutaneous Malassezia flora in atopic dermatitis differs between adults and children, Br J Dermatol, 2007, 157, 1178–1182[Crossref]
  • [28] Devos S.A., van der Valk P.G., The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis, Allergy, 2000, 55, 1056–1058[Crossref]
  • [29] Hanifin J.M., Rajka G., Diagnostic features of atopic dermatitis, Acta Derm Venereol, 1980, 92, 44–47
  • [30] Kurtzman C.P., Fell J.W., The yeasts, a taxonomic study, 4th edn., Amsterdam: Elsevier Science Publishing, 1998
  • [31] Guillot J., Guého E., Lesourd G., Midgley G., Cheevrier G., Dupont B., Identification of Malassezia species. A practical approach, J Mycol Med, 1996, 6, 103–110
  • [32] Guého E., Midgley G., Guillot J., The genus Malassezia with description of four new species, Antonie Leeuwenhoek, 1996, 69, 337–355[Crossref]
  • [33] Mayser P., Haze P., Papavassilis C., Pickel M., Gruender K., Gueho E., Differentiation of Malassezia species: selectivity of cremophor EL, castor oil and ricinoleic acid for M.furfur, Br J Dermatol, 1997, 137, 208–213[Crossref]
  • [34] Mayser P., Töws A., Krämer H.J., Weiß R., Further characterization of pigment-producing Malassezia strains, Mycoses, 2004, 47, 34–39[Crossref]
  • [35] Mayser P., Wille G., Imkampe A., Thoma W., Monsees T., Arnold N., Synthesis of fluorochromes and pigments in Malassezia furfur by use of tryptophan as the single nitrogen source, Mycoses, 1998, 41, 265–271[Crossref]
  • [36] Saghazadeh M., Farshi S., Hashemi J., Mansouri P., Khosravi A.R., Identification of Malassezia species isolated from patients with seborrheic dermatitis, atopic dermatitis, and normal subjects, J Mycol Med, (in press), DOI:10.1016/j.mycmed. 2010.08.003 [Crossref]
  • [37] Faergemann J., Atopic Dermatitis and Fungi, Clin Microbiol Rev, 2002, 15, 545–563[Crossref]
  • [38] Farhadi A., Banan A, Fields J., Keshavarzian A., Intestinal barrier: an interface between health and disease, J Gastroenterol Hepatol, 2003, 18, 479–497[Crossref]
  • [39] Yamaguchi N., Sugita R., Miki A., Takemura N., Kawataba J., Watanabe J., et al., Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice, 2006, 55, 954–960
  • [40] Akaza N., Akamatsu H., Sasaki Y., Takeoka S., Kishi M., Mizutani H., et al., Cutaneous Malassezia microbiota of healthy subjects differ by sex, body part and season, Journal of Dermatology, 2010, 37, 786–792[Crossref]
  • [41] Bunikowski R., Mielke M.E., Skarabis H., Worm M., Anagnostopoulos I., Kolde G., et al., Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis, J Allergy Clin Immunol, 2000, 105, 814–819[Crossref]
  • [42] Bunikowski R., Mielke M., Skarabis H., Herz U., Bergmann R.L., Wahn U., et al., Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis, J Allergy Clin Immunol, 1999, 103, 119–124[Crossref]
  • [43] Cunningham A.C., Ingham E., Gowland G., Humoral responces to Malassezia furfur serovars A, B and C in normal individuals of various ages, Br J Dermatol, 1992, 127, 476–481[Crossref]
  • [44] Gupta A.K., Batra R., Bluhm R., Boekhout T., Dawson T., Skin disease associated with Malassezia species, J Am Acad Dermatol, 2004, 51, 785–798[Crossref]
  • [45] Golubev W., Mycocins (Killer toxins), In: The yeasts, a taxonomic study, Kurtzman C.P., Fell J.W., 4th edn. Amsterdam: Elsevier Science Publishing, 1998
  • [46] Kitagaki H., Fujisawa S., Watanabe K., Hayakawa K., Shiohara T., Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice, J Invest Dermatol, 1995, 105, 749–755[Crossref]
  • [47] Hemmann S., Blaser K., Crameri R., Allergens of Aspergillus fumigatus and Candida boidinii Share IgE-binding Epitopes, Am J Respir Crit Care Med, 1997, 156, 1956–1962
  • [48] Sharma V., Singh B.P., Gaur S.N., Arora N., Molecular and immunological characterization of cytochrome c: a potential cross-reactive allergen in fungi and grasses, Allergy, 2008, 63, 189–197[Crossref]
  • [49] Simon-Nobbe B., Probst G., Kajava A.V., Oberkofler H., Susani M., Crameri R., et al., IgE-binding epitopes of enolases, a class of highly conserved fungal allergens, J Allergy Clin Immunol, 2000, 106, 887–895[Crossref]
  • [50] Shankar J., Gupta P.D., Sridhara S., Singh B.P., Gaur S.N., Arora N., Immunobiochemical analysis of cross-reactive glutathione-S-transferase allergen from different fungal sources, Immunol Invest, 2005, 34, 37–51
  • [51] Pöll V., Denk U., Shen H.D., Panzani R.C., Dissertori O., Lackner P., et al., The vacuolar serine protease, a cross-reactive allergen from Cladosporium herbarum, Mol Immunol, 2009, 46, 1360–1373[Crossref]
  • [52] Simon-Nobbe B., Denk U., Pöll V., Rid R., Breitenbach M., The spectrum of fungal allergy, Int Arch Allergy Immunol, 2008, 145, 58–86[Crossref]
  • [53] Kanbe T., Utsunomiya K., Ishiguro A., A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species, Clin Exp Allergy, 1997, 27, 1449–1457[Crossref]
  • [54] Savolainen J., Kortekangas-Savolainen O., Nermes M., Viander M., Koivikko A., Kalimo K., et al., IgE, IgA and IgG responses to common yeasts in atopic patients, Allergy, 1998, 53, 506–512[Crossref]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.